Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials

Dietary Intake of Advanced Glycation End Products Did Not Affect Endothelial Function and Inflammation in Healthy Adults in a Randomized Controlled Trial

(2014) Richard D. Semba et al.   JOURNAL OF NUTRITION

Maillard reaction products modulate gut microbiota composition in adolescents

(2014) Isabel Seiquer et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Effect of advanced glycation end product intake on inflammation and aging: a systematic review

(2014) Katrien Van Puyvelde et al.   NUTRITION REVIEWS

Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases

(2013) Jaime Uribarri et al.   AMINO ACIDS

Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women

(2013) Alicja Budek Mark et al.   DIABETES CARE

Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review

(2013) N J Kellow et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus

(2012) Claudia Luévano-Contreras et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events

(2012) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The pro- and anti-inflammatory properties of the cytokine interleukin-6

(2011) Jürgen Scheller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Advanced Glycation End Products Are Direct Modulators of  -Cell Function

(2011) M. T. Coughlan et al.   DIABETES

Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1

(2011) J. Uribarri et al.   DIABETES CARE

Targeted reduction of advanced glycation improves renal function in obesity

(2011) Brooke E. Harcourt et al.   KIDNEY INTERNATIONAL

Priority actions for the non-communicable disease crisis

(2011) Robert Beaglehole et al.   LANCET

A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases

(2010) Inès Birlouez-Aragon et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

(2009) P. D. Cani et al.   GUT

Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1

(2009) Helen Vlassara et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Strategy for the Study of the Health Impact of Dietary Maillard Products in Clinical Studies

(2008) Philippe Pouillart et al.   Annals of the New York Academy of Sciences

Determination ofNɛ-(Carboxymethyl)lysine in Foods and Related Systems

(2008) Jennifer M. Ames   Annals of the New York Academy of Sciences

F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications

(2008) Samar Basu   ANTIOXIDANTS & REDOX SIGNALING

Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

(2008) J. M. Forbes et al.   DIABETES

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice

(2008) P. D. Cani et al.   DIABETES